Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc. (Delaware) is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. Actinium Pharmaceuticals Inc. (Delaware) could be a weak company given it's low Piotroski F-score. The momentum for this stock is not very good. Actinium Pharmaceuticals Inc. (Delaware) has good growth characteristics. Actinium Pharmaceuticals Inc. (Delaware) is not very popular among insiders. Actinium Pharmaceuticals Inc. (Delaware) is a mediocre stock to choose.

Actinium Pharmaceuticals, Inc. is a clinical-stage, Biopharmaceutical Company focused on developing...

News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM

PR Newswire SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of...\n more…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM

Actinium Pharmaceuticals, Inc. (ATNM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Globe Newswire NEW YORK, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Actinium Pharmaceuticals, Inc...\n more…

Actinium Pharmaceuticals, Inc. (ATNM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Business Wire Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Actinium Pharmaceuticals, Inc. (Actinium or the Company) (NYSE: ATNM). Investors...\n more…